Table of Contents
Whether you are looking for early phase non-GMP manufacturing, custom synthesis or analytical research, J-STAR Research, Inc. is a contract chemistry organization that can help you solve your organic synthesis problems. It is a leading provider of organic synthesis solutions, serving the pharmaceutical and biotechnology industries.
Whether you are a chemist looking for a new challenge or a pharmacovigilance manager looking for a new company, J-Star Research offers a full suite of contract research and development services. Their services include custom synthesis and contract research, process and analytical research, and early phase non-GMP manufacturing. The company is headquartered in central New Jersey, and supports a variety of therapeutic areas, including drug substance optimization, pharmaceutical drug candidate advancement, and integrated solutions.
J-Star is known for its commitment to quality and dependability. Their team of 50 PhD process chemists is well-positioned to take your drug candidate from concept to commercialization. With extensive expertise in process chemistry, chemists at J-Star can assist with all aspects of your project, from program design to budget management.
Custom synthesis/contract research
Using a Custom Synthesis/Contract Research Organization can save you money and time. However, you need to be sure that the outsourcing partner has the necessary skills and experience. The right partner will be able to understand the regulations and provide you with external scientific input and know-how.
Custom synthesis/Contract Research Organizations offer a variety of services, from the development of process routes to the design of manufacturing processes. The process can vary from simple to complex, depending on the needs of the customer.
Custom Synthesis/Contract Research Organizations (cCROs) are an emerging form of outsourcing that is a result of changes in the commercial research culture. This type of organization is an outsourced research facility that specializes in the development of active pharmaceutical ingredients (APIs) and small molecules for commercial use.
Founded in 1996, J-Star is a contract chemistry organization that provides a full range of testing and research services to the pharmaceutical industry. They offer services for drug product development, testing for APIs, early formulation, and release testing. They also have a robust stability testing program that provides a wide range of services, including visual assessment of API interaction with containers and closure mechanisms, as well as the analysis of apparent trends over time.
The J-STAR staff has extensive experience in pharmaceutical process development. They are adept at meeting target timeframes while delivering the highest quality materials to their clients. They also have the ability to make sense of a complex and dynamic preclinical and clinical R&D space. With their services, clients can re-design the entire route for key intermediates and remove expensive steps, saving money in the process.
Founded in 1996 by Andrew Thompson, J-Star Research is a contract research organization (CRO) that provides organic synthesis and crystallization services to the biotechnology industry. The company has been recognized for its high quality and dependability. They are known for their ability to work with dynamic preclinical and clinical R&D areas. The organization has developed into a multidisciplinary team of over 100 employees. Most of them hold PhD degrees.
J-Star has gained an impressive client base of large pharmaceutical companies. They provide a wide range of services including solid form screening, impurity isolation and catalysis screening. They also offer QC and quality assurance services. J-Star follows ICH Q2A, B, C, and E guidelines for their quality control procedures.
J-Star is a leading provider of complex organic synthesis. They offer cGMP manufacturing services. They have a USFDA-inspected cGMP production facility in China and sales offices in North America, Europe, and Asia. They also provide drug substance R&D services.
Porton Fine Chemicals
Despite the fact that Porton Fine Chemicals is headquartered in China, the company is planning to open a facility in the US this year. It has recently acquired South Plainfield, New Jersey-based J-Star Research, Inc., and will pay $26 million for the contract research organization.
J-STAR is a contract chemistry organization that offers process research, custom synthesis, and analytical services. The organization was founded by Dr. Andrew Thompson, and it currently has a staff of 47 people. It offers services for the early phase clinical development of small molecule APIs and crystallization research and development.
J-STAR was formed in 1996 and serves as an outsourcing partner to the pharmaceutical industry. It has a staff of 32 PhDs. The organization offers its services to clients in the biotechnology, pharmaceutical, and chemical industries. The company has received several awards for its contributions to the industry.